Answers are grounded in this paper and cite their sources.
Observational study shows fucoidan's potential to reduce kidney fibrosis in chronic kidney disease, suggesting a new therapeutic approach.
Chronic kidney disease (CKD) is a major global health burden, with renal fibrosis as the key pathological driver of disease progression. Fucoidan (FPS) is a sulfated polysaccharide from brown algae...
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: